Treatment for Costochondritis
The first-line treatment for costochondritis is NSAIDs at maximum tolerated and approved dosage, with evaluation of treatment response after 2-4 weeks. 1
Pharmacological Management
- Start with NSAIDs/COXIBs at maximum tolerated and approved dosage as first-line treatment 1
- Evaluate treatment response after 2-4 weeks; if sufficient response, continue and re-evaluate at 12 weeks 1
- Consider NSAID/COXIB rotation if insufficient response at 2-4 weeks 1
- Short courses of oral prednisolone or intra-articular glucocorticoid injections may be considered as bridging options while awaiting the effect of other agents 1
- Avoid long-term use of glucocorticoids due to potential adverse effects 1
- For pain relief, regular dosing of acetaminophen (paracetamol) may be needed as an alternative or adjunct 1
- Topical NSAIDs can be considered before oral NSAIDs to minimize systemic side effects 1
- Use oral NSAIDs at the lowest effective dose for the shortest possible period of time to minimize risks 1
Non-Pharmacological Interventions
- Provide patient education about the condition and lifestyle recommendations 1
- Consider physiotherapy, which has shown effectiveness in case studies 1, 2
- Apply local heat or cold applications to the affected area 1
- Implement stretching exercises, which have demonstrated significant pain reduction in patients with costochondritis 3
- Consider manual therapy techniques including rib manipulation and soft tissue mobilization, which have shown complete resolution of symptoms in some cases 4
- Recommend activity modification to avoid movements that exacerbate pain 5
- Consider instrument-assisted soft tissue mobilization (IASTM) for myofascial pain generators 4
Treatment Algorithm
Initial Management:
After 2-4 weeks, assess response:
Second-line options:
For persistent cases (atypical costochondritis):
Special Considerations
- Rule out more serious causes of chest pain before confirming diagnosis of costochondritis, especially in patients over 35 years or with cardiac risk factors 5
- Distinguish between non-infectious costochondritis (more common) and infectious costochondritis, which requires antibiotics and possibly surgical debridement 6
- Costochondritis is typically self-limiting but can persist for several weeks to months; persistent cases (atypical costochondritis) may require more aggressive physical therapy intervention 4, 5
- Monitor for gastrointestinal, liver, and cardiorenal toxicity with prolonged NSAID use, particularly in elderly patients and those with comorbidities 1
Treatment Efficacy
- Physical therapy utilizing manual therapy and therapeutic exercise has shown promising results with clinically meaningful improvements in pain and function 2
- Stretching exercises have demonstrated progressive significant improvement compared to control groups 3
- Complete resolution of symptoms has been reported after rib manipulation and soft tissue mobilization in some cases 4
- Traditional pharmacological treatment with NSAIDs is effective for most cases but may be insufficient for persistent symptoms 5, 3